Importance of Sinus Rhythm as Endpoint of Persistent Atrial Fibrillation Ablation

• Published in: Journal of cardiovascular electrophysiology 2013-04, Vol.24 (4), p.388-395
• Main Authors: AMMAR, SONIA, HESSLING, GABRIELE, REENTS, TILKO, PAULIK, MARIA, FICHTNER, STEPHANIE, SCHÖN, PATRICK, DILLIER, ROGER, KATHAN, SUSANNE, JILEK, CLEMENS, KOLB, CHRISTOF, HALLER, BERNHARD, DEISENHOFER, ISABEL
• Format: Article
• Language: English
• Subjects: acute termination; Adult; Aged; Anti-Arrhythmia Agents - therapeutic use; atrial fibrillation; Atrial Fibrillation - diagnosis; Atrial Fibrillation - physiopathology; Atrial Fibrillation - surgery; Cardiac arrhythmia; catheter ablation; Catheter Ablation - adverse effects; Chi-Square Distribution; complex fractionated atrial electrograms; Disease-Free Survival; Electric Countershock; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Female; Heart Conduction System - physiopathology; Heart Conduction System - surgery; Humans; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; pulmonary vein isolation; Pulmonary Veins - physiopathology; Pulmonary Veins - surgery; Recurrence; Risk Factors; Tachycardia, Supraventricular - etiology; Tachycardia, Supraventricular - physiopathology; Tachycardia, Supraventricular - therapy; Time Factors; Treatment Outcome
• ISSN: 1045-3873; 1540-8167
• DOI: 10.1111/jce.12045

Endpoint of Persistent AF Ablation. Background: The endpoint of persistent atrial fibrillation (AF) ablation is still a matter of debate. The purpose of this study was to evaluate if sinus rhythm (SR) as endpoint of persistent AF ablation has a better long‐term outcome compared to atrial tachycardia (AT) or AF at the end of the procedure. Methods and Results: Between 2008 and 2011, 191 consecutive patients undergoing de novo catheter ablation for symptomatic persistent and long‐standing persistent AF using a sequential ablation approach (including pulmonary vein isolation, ablation of complex fractionated electrograms and linear lesions) were included in the study. According to the result at the end of ablation procedure, patients were classified into 3 groups: patients with termination of AF into SR (Group 1, n = 62), patients with AT undergoing cardioversion (CV) (Group 2, n = 47), or patients with AF undergoing CV (Group 3, n = 82). The primary endpoint was freedom from any atrial tachyarrhythmia off antiarrhythmic drugs at 12 months. At 12 months, estimated proportions of patients free from any arrhythmia recurrence were 42% for Group 1, 13% for Group 2, and 25% for Group 3 (P = 0.002). In a Cox regression analysis only termination into SR was associated with a lower risk of arrhythmia recurrence (HR: 0.62; P = 0.04). Conclusion: If SR is achieved as endpoint of persistent and long‐standing persistent AF ablation using a sequential ablation approach it is associated with the highest long‐term single procedure success rate compared to AT or AF at the end of the procedure. (J Cardiovasc Electrophysiol, Vol. 24, pp. 388‐395, April 2013)